International Journal of Clinical Endocrinology and Metabolism

Journal Information
EISSN: 26407582
Total articles ≅ 43

Latest articles in this journal

Kang Tae-Bong, Hisham Yasmin, Lee Youngmin, Jhun Hyunjhung, Kim Joohee,
International Journal of Clinical Endocrinology and Metabolism, Volume 8, pp 001-008; https://doi.org/10.17352/ijcem.000054

Abstract:
People with diabetes are at increased risk of infection and are worried about biological agents such as bacteria. Particularly, foot infections, urinary tract infections, pneumonia, and skin diseases are due to bacterial infections that make diabetic patients suffer from clinical difficulties. Although antibiotics, one of the bacterial therapies, have been used, the emergence of multidrug-resistant bacteria is now in demand for alternative therapies. Although, many studies reported that antibiotic-resistant for bacterial infections and their rate have increased significantly in the diabetic patient population. Still, there is no report that directly compares the prevalence of antibiotic-resistant infections in diabetes types. In this review, we described the diverse types of diabetes with their bacterial infection and the reported resistance. Generally, diabetic patients are susceptible to vancomycin-resistant enterococcal infections, extended-spectrum β-lactamase-producing intestinal bacteria, carbapenem-resistant intestinal bacteria, and unfermented gram-negative bacilli. Thus, early detection of diabetes and prompt treatment are important to control chronic infections in diabetic patients.
Hevroni Gil, Skwiersky Samara, Zhyvotovska Angelina,
International Journal of Clinical Endocrinology and Metabolism, Volume 6, pp 035-041; https://doi.org/10.17352/ijcem.000052

Abstract:
Metformin use has been associated with a decreased risk of cancer and improvement in overall cancer survival rates. However, scant data available regarding metformin’s role in the risk of Gastrointestinal (GI) malignancies in patients with type II diabetes. Our study aimed to conduct a meta-analysis to evaluate the association of metformin use and GI cancer risk. We conducted electronic search by two independent investigators using the PubMed and Cochrane library databases. Studies were assessed for design and quality, and a meta-analysis was conducted to quantify the effect of metformin on the odds of developing specific GI malignancies. The final papers that met our prespecified inclusion criteria included 4 case-control studies that address metformin’s effect on pancreatic cancer, and 4 case-control studies that address metformin’s effect on colorectal cancer in patients with type II DM. Of 2258 articles screened, 8 eligible studies were identified comprising 483,561 participants diagnosed with DM. Our analysis showed that metformin use was not associated with a significant effect on the odds of developing pancreatic cancer (OR .98; 95% CI 0.82–1.17, P=0. 83). Metformin use was associated with significantly lower odds of having Colorectal Cancer (CRC); (OR 0.84; 95% CI 0.81–0.87, p < 0.01). Sufficient data were not available to conduct analyses on the impact of metformin dose and duration. Our findings suggest that metformin could be a useful neoadjuvant agent for CRC cancer and as a possible preventive therapy for other inflammatory conditions related to colorectal pathologies such as adenomatous polyps and inflammatory bowel disease. Further research is warranted to elucidate the role of metformin on the risk of developing pancreatic cancer, given the complex nature of the organ’s regulation on insulin production.
Cao Peng, Wu Sanlan, Wu Tingting, Zhang Qilin, Zhang Rui, Zhang Yu
International Journal of Clinical Endocrinology and Metabolism, Volume 6, pp 033-034; https://doi.org/10.17352/ijcem.000051

, Gomes Richmond Ronald, Rahman Km Thouhidur, Hasan Abm Kamrul, Fahim Shah Mohammad
International Journal of Clinical Endocrinology and Metabolism, Volume 6, pp 025-029; https://doi.org/10.17352/ijcem.000049

Abstract:
The aim of this study is to compare the risk factors, management and pregnancy outcome between the Gestational Diabetes Mellitus (GDM) patients who were diagnosed at early and late stage of pregnancy.
Ober Clinton, Oschman James L
International Journal of Clinical Endocrinology and Metabolism, Volume 6, pp 022-024; https://doi.org/10.17352/ijcem.000048

Abstract:
The sudden onset of a viral pandemic has led to an urgent situation in which health professionals are looking for something “out of the box” to remedy the crisis.
Hakeem Arsheed Hussain, Javaid Hassaan, Rallabandi Hima Bindu, Wani Fozia Jeelani
International Journal of Clinical Endocrinology and Metabolism, Volume 6, pp 017-021; https://doi.org/10.17352/ijcem.000047

Mohakuda Sourya Sourabh, Thakur Rajneesh,
International Journal of Clinical Endocrinology and Metabolism, Volume 6, pp 008-010; https://doi.org/10.17352/ijcem.000044

Back to Top Top